Chris Painter

Chris Painter’s research focuses on using health economics and health technology assessment (HTA) methods to inform resource allocation policy decisions and maximise the use of limited healthcare resources. He applies these methods to a wide range of communicable and non-communicable diseases.

A Health Economist at MORU MAEMOD’s Neglected Tropical Diseases Modeling (NTDM) Group since 2022, Chris’ current work primarily focusses on the economics of antimicrobial resistance (AMR), diagnostics, febrile illness and other tropical diseases. Chris is also part of LOMWRU in Lao PDR, conducting research to support the Unit for Health Evidence and Policy, a recent HTA initiative which generates evidence to inform decision-making on health policy priority issues in the country.

Chris' recent projects include: (ACORN) A Clinically Oriented antimicrobial Resistance Network; the ACT-South Asia (Azithromycin and Cefixime treatment of typhoid in South Asia) trial. Chris is currently working on a variety of economic analyses related to AMR surveillance and antimicrobial stewardship, thalasssemia screening programs, and for referral algorithms and rapid diagnostic tests.

Prior to joining MORU, Chris worked as an Overseas Development Institute Fellow (2019-2022) at the Health Intervention and Technology Assessment Program (HITAP) in Thailand’s Ministry of Public Health.